BRCA Founder OutReach (BFOR) Study

Running, not enrolling

Conditions studied: BRCA1 Mutation, BRCA2 Mutation

In brief

The purpose of this study is to learn how to provide BRCA gene testing to a larger number of people as well as to make testing part of a person's regular medical care.

Key facts

Study ID

NCT03351803

Run by

Memorial Sloan Kettering Cancer Center

People needed

5412

Starts

2017-11-10

Expected to finish

2027-05-10

Last updated by the study team

2026-05-28

Who can join

Age: 25 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Self-reported age ≥ 25
• Self identify as having at least one of their four grandparents as Ashkenazi Jewish
• Has medical insurance
• Able to understand and read the English-language
• Zip code falls within the catchment areas of the phase of the study (e.g. New York City, Boston, Philadelphia, Los Angeles) accessible to a BFOR designated provider

You may not qualify if…

• Under age 25
• No Ashkenazi Jewish ancestry
• Does not have insurance
• Has previously had medical BRCA testing ordered by a health care provider

Where it is running

• University of California, Los Angeles — Los Angeles, California, United States
• Dana Farber Cancer Institute — Boston, Massachusetts, United States
• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
• Memorial Sloan - Kettering Cancer Center — New York, New York, United States
• University of Pennsylvania — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.